Guy Heynen

Dr. Guy Heynen, MD, is a Chief Executive Officer at Guy Heynen Consulting.
He is on the Board of Directors at AbolerIS Pharma, Acticor Biotech SAS, Adipopharma SAS and NeuVasQ Biotechnologies SA. Dr. Heynen was previously employed as a Director-Medical Affairs by Anbics AG, a Chief Medical, Clinical & Regulatory Officer by Bone Therapeutics SA, a Principal by Centre Hospitalier Universitaire de Liege, a President by Creativenture SA, a Non-Executive Director by Ogeda SA, a Medical Director by Pfizer AG, a Medical Team Leader by Pfizer Inc., and a President by ProGenosis SA. He also served on the board at ChromaCure SA, Dim3 SA, Ncardia SA and Pluriomics BV.
He received his doctorate degree from Centre Hospitalier Universitaire de Liege.